Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies
NCT01126697
Becker Muscular Dystrophy, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Washington D.C., District of Columbia, United States
View Trial DetailsNCT Number: NCT01066455
The purpose of the research study is to evaluate different cardiac measures that are obtained by echocardiographic tests in patients with muscular dystrophy.
Looking for future studies?
Notify Me8 year–18 year
All sexes
Observational
University of California Davis, Sacramento, California, United States
The research study will include 50 participants aged 8 to 18 years old (before 18th birthday) with Duchenne, Becker, or autosomal recessive limb-girdle (specifically: LGMD 2C-2F and 2I) muscular dystrophies.
Participants will be seen in one of five Cooperative International Neuromuscular Research Group (CINRG) centers located in the United States.
All study assessments will be completed in the same day and include reviewing past medical and surgical history, collecting vital signs, collecting cardiac measures through echocardiographic tests.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Cooperative International Neuromuscular Research Group
Network
PITT1109: Cardiac Outcome Measures in Children With Muscular Dystrophy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01126697
Becker Muscular Dystrophy, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Washington D.C., District of Columbia, United States
View Trial DetailsNCT00873782
Becker Muscular Dystrophy, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Chapel Hill, North Carolina, United States
View Trial DetailsNCT01081080
Becker Muscular Dystrophy, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Washington D.C., District of Columbia, United States
View Trial DetailsNCT02069756
Becker Muscular Dystrophy, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Washington D.C., District of Columbia, United States
View Trial Details